Fitch Assigns BBB Rating to Quest's Senior Notes Offering | GenomeWeb

NEW YORK (GenomeWeb) – Fitch Ratings has assigned a BBB rating to the $1.2 billion senior notes offering announced today by Quest Diagnostics. 

Fitch also said the rating outlook is stable. It said in a statement that the refinancing will raise Quest's debt leverage this year to be temporarily elevated but that it anticipates the debt to be repaid and Quest's total debt balances to be reduced to about $3.8 billion by the end of the year. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.